Lilly Lowers Zepbound's Single-dose Vials' Cost
Lilly has reduced the price of its Zepbound (tirzepatide) single-dose vials, reinforcing its commitment to improving affordability and expanding access for people living with obesity.
Single-dose Pen (autoinjector) | 02/12/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy